fluorodeoxyglucose f18 has been researched along with Peritonitis, Tuberculous in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, H; Lu, R; Wang, S; Xie, R; Xu, D | 1 |
| Goto, H; Saraya, T; Takizawa, H; Tsujimoto, N | 1 |
| Gaertner, FC; Hattori, N; Kobayashi, K; Manabe, O; Masuda, A; Tamaki, N; Watanabe, S | 1 |
| Aggrawal, K; Bhattacharya, A; Kochhar, R; Mittal, BR; Sharma, S | 1 |
| Chen, R; Chen, Y; Huang, G; Liu, J; Liu, L; Zhou, X | 1 |
| Hu, J; Ji, YH; Lv, L; Shou, T; Wang, QS; Wang, SB; Wu, HB; Zhou, WL | 1 |
| Boju, SL; C V, AK; Kalawat, TC; M, A; Mantri, RG; Mogili, HK; R, R; V, SK | 1 |
| Hayashi, N; Igura, T; Kamada, Y; Nishida, T; Tsutsui, S; Wada, A; Watabe, K; Yakushijin, T; Yamamoto, K; Yamamoto, S | 1 |
| Hwang, JH; Kim, SE; Lee, JK | 1 |
| Ichikawa, T; Mori, M; Takagi, H | 1 |
| Itsukaichi, M; Mashima, Y; Tanaka, K; Yahata, T | 1 |
| Camatte, S; Jeffry, L; Kerrou, K; Lécuru, F; Lelievre, L; Metzger, U; Robin, F; Talbot, JN | 1 |
| Bruno, GL; Lilien, DL; Reddy, M; Takalkar, AM | 1 |
| Aozasa, K; Hamada, K; Hatazawa, J; Higuchi, I; Nonomura, N; Okuyama, A; Shimamoto, H; Tomita, Y; Tsujihata, M | 1 |
14 other study(ies) available for fluorodeoxyglucose f18 and Peritonitis, Tuberculous
| Article | Year |
|---|---|
Characterizing omental PET/CT findings for differentiating tuberculous peritonitis from peritoneal carcinomatosis.
Topics: Fluorodeoxyglucose F18; Humans; Omentum; Peritoneal Neoplasms; Peritonitis, Tuberculous; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Tuberculous peritonitis incidentally diagnosed on FDG-PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Peritonitis, Tuberculous; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Treatment monitoring with (18)F-FDG PET/CT in a patient with peritoneal tuberculosis.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Peritonitis, Tuberculous; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
18F-FDG and FDG-labeled leukocyte PET/CT in peritoneal tuberculosis.
Topics: Fluorodeoxyglucose F18; Humans; Leukocytes; Male; Multimodal Imaging; Peritonitis, Tuberculous; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2014 |
The Role of ¹⁸F-FDG PET/CT in the Evaluation of Peritoneal Thickening of Undetermined Origin.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Peritoneal Diseases; Peritonitis, Tuberculous; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Peritoneum; Peritonitis, Tuberculous; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2017 |
Tuberculous peritonitis diagnosed with the help of 18 F-FDG PET/CT scan.
Topics: Adult; Antitubercular Agents; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis, Tuberculous; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Whole Body Imaging | 2017 |
[18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) was useful tool for detecting tuberculous peritonitis: report of a case].
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Peritonitis, Tuberculous; Positron-Emission Tomography | 2008 |
F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic tuberculosis mimicking peritoneal carcinomatosis.
Topics: Aged; Ascites; CA-125 Antigen; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Peritoneal Neoplasms; Peritonitis, Tuberculous; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2009 |
Abdominal tuberculosis in the absence of pulmonary involvement shown by 2-[fluorine 18] fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Fluorodeoxyglucose F18; Histocytochemistry; Humans; Ileum; Intestinal Mucosa; Male; Microscopy; Middle Aged; Peritoneum; Peritonitis, Tuberculous; Positron-Emission Tomography; Radiography, Abdominal; Radiopharmaceuticals; Tuberculosis, Gastrointestinal | 2009 |
Antituberculosis treatment for a patient with massive ascites: the role of f-18-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Antitubercular Agents; Ascites; Female; Fluorodeoxyglucose F18; Humans; Peritonitis, Tuberculous; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Peritoneal tuberculosis revealed by carcinomatosis on CT scan and uptake at FDG-PET.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Pelvic Neoplasms; Peritonitis, Tuberculous; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Intense FDG activity in peritoneal tuberculosis mimics peritoneal carcinomatosis.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Peritonitis, Tuberculous; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Abdominal Tuberculosis: peritoneal involvement shown by F-18 FDG PET.
Topics: Abdomen; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Peritonitis, Tuberculous; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |